Key Issues in FDA & FTC Regulation of Dietary Supplements 2013 is a webinar that covers topics such as:
- Recent FDA enforcement action on dietary supplement GMPs
- Overview of dietary supplement regulation
- Understanding when claims convert a dietary supplement into a drug and the consequences of the resulting unapproved new drug status
- Changes in FDA’s New Dietary Ingredient (NDI) requirements
- The FTC’s decision in POM Wonderful and its implications for claims substantiation
Key Issues in FDA & FTC Regulation of Dietary Supplements 2013 brings together C-Suite / Senior Executives from dietary supplement companies involved in:
- Quality Assurance
- Manufacturing
- Compliance
- Regulatory Affairs
- Marketing
- Sales
- Scientific Affairs
- Legal
- Clinical